AU5095393A - Pharmaceutical compositions containing nonionic surfactants - Google Patents

Pharmaceutical compositions containing nonionic surfactants

Info

Publication number
AU5095393A
AU5095393A AU50953/93A AU5095393A AU5095393A AU 5095393 A AU5095393 A AU 5095393A AU 50953/93 A AU50953/93 A AU 50953/93A AU 5095393 A AU5095393 A AU 5095393A AU 5095393 A AU5095393 A AU 5095393A
Authority
AU
Australia
Prior art keywords
active agent
nonionic surfactant
polyoxyethylene
composition according
ethoxylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50953/93A
Other languages
English (en)
Inventor
William J Curatolo
Michael J Gumkowski
Julian B Lo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of AU5095393A publication Critical patent/AU5095393A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU50953/93A 1992-10-02 1993-09-02 Pharmaceutical compositions containing nonionic surfactants Abandoned AU5095393A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95596292A 1992-10-02 1992-10-02
US955962 1992-10-02
PCT/US1993/008107 WO1994007472A1 (en) 1992-10-02 1993-09-02 Pharmaceutical compositions containing nonionic surfactants

Publications (1)

Publication Number Publication Date
AU5095393A true AU5095393A (en) 1994-04-26

Family

ID=25497602

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50953/93A Abandoned AU5095393A (en) 1992-10-02 1993-09-02 Pharmaceutical compositions containing nonionic surfactants

Country Status (12)

Country Link
EP (1) EP0662826A1 (no)
JP (1) JPH07507565A (no)
KR (1) KR950703333A (no)
AU (1) AU5095393A (no)
CA (1) CA2145763A1 (no)
FI (1) FI934317A (no)
HU (1) HUT69400A (no)
IL (1) IL107084A0 (no)
MX (1) MX9306125A (no)
TW (1) TW253838B (no)
WO (1) WO1994007472A1 (no)
ZA (1) ZA937268B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1808897A (en) * 1995-12-13 1997-07-03 Dullatur Limited A calcitonin preparation
SE9602145D0 (sv) * 1996-05-31 1996-05-31 Astra Ab New improved formulation for treatment of thromboembolism
JP5300477B2 (ja) * 2006-08-01 2013-09-25 大塚製薬株式会社 薬理活性物質の吸収性が改善された医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS6233128A (ja) * 1985-08-07 1987-02-13 Toray Ind Inc インタ−フエロン腸溶性経口用製剤
EP0351651B1 (en) * 1988-07-21 1993-09-15 F. Hoffmann-La Roche Ag Insulin preparation
AU1256692A (en) * 1991-02-06 1992-09-07 Schering Corporation Combination of an angiotensin II antagonist or renin inhibitor with a neutral endopeptidase inhibitor
CA2125400A1 (en) * 1991-12-18 1993-06-24 Gordon L. Amidon Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation

Also Published As

Publication number Publication date
IL107084A0 (en) 1993-12-28
HUT69400A (en) 1995-09-28
WO1994007472A1 (en) 1994-04-14
FI934317A (fi) 1994-04-03
JPH07507565A (ja) 1995-08-24
HU9302774D0 (en) 1993-12-28
KR950703333A (ko) 1995-09-20
FI934317A0 (fi) 1993-10-01
CA2145763A1 (en) 1994-04-14
ZA937268B (en) 1995-03-30
MX9306125A (es) 1994-04-29
TW253838B (no) 1995-08-11
EP0662826A1 (en) 1995-07-19

Similar Documents

Publication Publication Date Title
RU2198677C2 (ru) Фармацевтическая композиция для пероральной доставки физиологически активного пептидного агента и способ усиления его биодоступности
EP0843558B1 (en) Composition for enhanced uptake of polar drugs from the colon
AU617157B2 (en) Intravaginal delivery of biologically active polypeptides
JP5100334B2 (ja) カプセル封入されたドラッグデリバリー用透明液
EP0387352B1 (en) Enteric formulations of physiologically active peptides and proteins
US4889723A (en) Pharmaceutical compositions comprising esters or amides as active ingredients
JP2003506476A (ja) 親水性治療剤の増強された吸収のための組成物および方法
CN103458873A (zh) 用于口服肽递送的脂肪酸酰化的氨基酸
Li et al. Oil‐based formulations for oral delivery of insulin
CA2138607A1 (en) Formulations for orally administered pharmaceutical agents
AU5095393A (en) Pharmaceutical compositions containing nonionic surfactants
JP3181062B2 (ja) 下部消化管崩壊経口製剤
US20220249468A1 (en) Formulation for oral delivery of proteins, peptides and small molecules with poor permeability
WO1995006463A1 (en) Pharmaceutical compositions containing anionic surfactants
JP2005272416A (ja) 消化管粘膜付着性ｄｄｓを用いる赤血球増殖因子エリスロポエチン類およびインターフェロン類の経口製剤
JPH0764755B2 (ja) 経粘膜投与用組成物
JPH0510329B2 (no)